LEVITRA

Administration of LEVITRA with nitrates and nitric oxide donors is contraindicated. Consistent with the effects of PDE5 inhibition on the nitric oxide/cyclic guanosine monophosphate pathway, PDE5 inhibitors, including LEVITRA, may potentiate the hypotensive effects of nitrates

...continue reading

Please see complete Prescribing Information, including Patient Information Leaflet, by clicking the ["Prescribing Information"] navigation above.